Optimizing treatment approaches for patients with cutaneous melanoma by integrating clinical and pathologic features with the 31-gene expression profile test.
Saved in:
| Title: | Optimizing treatment approaches for patients with cutaneous melanoma by integrating clinical and pathologic features with the 31-gene expression profile test. |
|---|---|
| Authors: | Jarell A; Northeast Dermatology Associates, PC, Portsmouth, New Hampshire., Gastman BR; Cleveland Clinic Lerner Research Institute, Cleveland, Ohio., Dillon LD; Surgical Oncology & General Surgery, Colorado Springs, Colorado., Hsueh EC; Department of Surgery, St Louis University, St Louis, Missouri., Podlipnik S; Dermatology Department, Hospital Clínic Barcelona, University of Barcelona, IDIBAPS, Barcelona, Spain. & Centro de investigaciones Biomédicas en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Barcelona, Spain., Covington KR; Research and Development, Castle Biosciences, Inc, Friendswood, Texas., Cook RW; Research and Development, Castle Biosciences, Inc, Friendswood, Texas. Electronic address: rcook@castlebiosciences.com., Bailey CN; Research and Development, Castle Biosciences, Inc, Friendswood, Texas., Quick AP; Research and Development, Castle Biosciences, Inc, Friendswood, Texas., Martin BJ; Research and Development, Castle Biosciences, Inc, Friendswood, Texas., Kurley SJ; Research and Development, Castle Biosciences, Inc, Friendswood, Texas., Goldberg MS; Research and Development, Castle Biosciences, Inc, Friendswood, Texas. Electronic address: mgoldberg@castlebiosciences.com., Puig S; Dermatology Department, Hospital Clínic Barcelona, University of Barcelona, IDIBAPS, Barcelona, Spain. & Centro de investigaciones Biomédicas en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Barcelona, Spain. |
| Source: | Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2022 Dec; Vol. 87 (6), pp. 1312-1320. Date of Electronic Publication: 2022 Jul 08. |
| Publication Type: | Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787 (Electronic) Linking ISSN: 01909622 NLM ISO Abbreviation: J Am Acad Dermatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35810840 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Optimizing treatment approaches for patients with cutaneous melanoma by integrating clinical and pathologic features with the 31-gene expression profile test. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Jarell+A%22">Jarell A</searchLink>; Northeast Dermatology Associates, PC, Portsmouth, New Hampshire.<br /><searchLink fieldCode="AU" term="%22Gastman+BR%22">Gastman BR</searchLink>; Cleveland Clinic Lerner Research Institute, Cleveland, Ohio.<br /><searchLink fieldCode="AU" term="%22Dillon+LD%22">Dillon LD</searchLink>; Surgical Oncology & General Surgery, Colorado Springs, Colorado.<br /><searchLink fieldCode="AU" term="%22Hsueh+EC%22">Hsueh EC</searchLink>; Department of Surgery, St Louis University, St Louis, Missouri.<br /><searchLink fieldCode="AU" term="%22Podlipnik+S%22">Podlipnik S</searchLink>; Dermatology Department, Hospital Clínic Barcelona, University of Barcelona, IDIBAPS, Barcelona, Spain. & Centro de investigaciones Biomédicas en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Covington+KR%22">Covington KR</searchLink>; Research and Development, Castle Biosciences, Inc, Friendswood, Texas.<br /><searchLink fieldCode="AU" term="%22Cook+RW%22">Cook RW</searchLink>; Research and Development, Castle Biosciences, Inc, Friendswood, Texas. Electronic address: rcook@castlebiosciences.com.<br /><searchLink fieldCode="AU" term="%22Bailey+CN%22">Bailey CN</searchLink>; Research and Development, Castle Biosciences, Inc, Friendswood, Texas.<br /><searchLink fieldCode="AU" term="%22Quick+AP%22">Quick AP</searchLink>; Research and Development, Castle Biosciences, Inc, Friendswood, Texas.<br /><searchLink fieldCode="AU" term="%22Martin+BJ%22">Martin BJ</searchLink>; Research and Development, Castle Biosciences, Inc, Friendswood, Texas.<br /><searchLink fieldCode="AU" term="%22Kurley+SJ%22">Kurley SJ</searchLink>; Research and Development, Castle Biosciences, Inc, Friendswood, Texas.<br /><searchLink fieldCode="AU" term="%22Goldberg+MS%22">Goldberg MS</searchLink>; Research and Development, Castle Biosciences, Inc, Friendswood, Texas. Electronic address: mgoldberg@castlebiosciences.com.<br /><searchLink fieldCode="AU" term="%22Puig+S%22">Puig S</searchLink>; Dermatology Department, Hospital Clínic Barcelona, University of Barcelona, IDIBAPS, Barcelona, Spain. & Centro de investigaciones Biomédicas en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Barcelona, Spain. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227907132%22">Journal of the American Academy of Dermatology</searchLink> [J Am Acad Dermatol] 2022 Dec; Vol. 87 (6), pp. 1312-1320. <i>Date of Electronic Publication: </i>2022 Jul 08. – Name: TypePub Label: Publication Type Group: TypPub Data: Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Mosby%22">Mosby </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7907132 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-6787 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201909622%22">01909622 </searchLink><i>NLM ISO Abbreviation: </i>J Am Acad Dermatol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35810840 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jaad.2022.06.1202 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1312 Titles: – TitleFull: Optimizing treatment approaches for patients with cutaneous melanoma by integrating clinical and pathologic features with the 31-gene expression profile test. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Jarell A – PersonEntity: Name: NameFull: Gastman BR – PersonEntity: Name: NameFull: Dillon LD – PersonEntity: Name: NameFull: Hsueh EC – PersonEntity: Name: NameFull: Podlipnik S – PersonEntity: Name: NameFull: Covington KR – PersonEntity: Name: NameFull: Cook RW – PersonEntity: Name: NameFull: Bailey CN – PersonEntity: Name: NameFull: Quick AP – PersonEntity: Name: NameFull: Martin BJ – PersonEntity: Name: NameFull: Kurley SJ – PersonEntity: Name: NameFull: Goldberg MS – PersonEntity: Name: NameFull: Puig S IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2022 Dec Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1097-6787 Numbering: – Type: volume Value: 87 – Type: issue Value: 6 Titles: – TitleFull: Journal of the American Academy of Dermatology Type: main |
| ResultId | 1 |
